# roflumilast

NDC: 73190-086
Generic name: ROFLUMILAST
Labeler / Manufacturer: AvKARE
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20260624

FDA application: ANDA208247

## Active ingredients

- ROFLUMILAST: 250 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73190-086"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73190-086
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=55009549-3f0c-1f58-e063-6294a90a6c03